These three brain tumor researchers are relentless in unraveling the mysteries of this formidable disease, cell by cell, experiment after experiment.
They are investigating drug compounds and proteins to stem the progression of aggressive tumors to pushing the boundaries of research into new approaches. Morgan Schrock, DVM, PhD, Trang Nguyen, PhD and Stephanie Seidlits, PhD are part of the community of scientists making important discoveries that may one day foster breakthroughs for brain tumors.
As recipients of the ABTA’s prestigious research grants, they received funding to support research that may have the potential to change the lives of people impacted by a brain tumor diagnosis.
Read more about the progress of their innovative brain tumor research since they received an ABTA grant and how it has impacted their careers.
![](https://www.abta.org/wp-content/uploads/2024/08/vorasidenib-blog-post-1.gif)
FDA Approves Vorasidenib, a New Treatment for Low-Grade Gliomas
A new treatment called Vorasidenib has been approved by the U.S. Food and Drug Administration (FDA) for people with low-grade gliomas (LGG). This type of brain tumor grows slowly but
![Michelle Kim](https://www.abta.org/wp-content/uploads/2024/08/Michelle-Kim-300x300.jpg)
Collaboration & Hope: Highlights from the SNO/ASCO Central Nervous System Metastases Conference
The SNO/ASCO Central Nervous System (CNS) Metastases Conference brought together leading experts, researchers, and clinicians from around the world to discuss the latest advancements in the understanding and treatment of
![Martin Hospina Meningioma patient](https://www.abta.org/wp-content/uploads/2024/08/Martin-Hospina-224x300.jpg)
My Life-Changing Experience
by Martin Hospina Diagnosed in 2011, with a meningioma that had to be removed surgically. It was too big for radiation treatment.After several surgeries, 2011-2016, I had to relearn to
Beyond Brain Tumor Breakthroughs
Since its inception, the ABTA Research program has awarded almost $33 million dollars to scientists with novel ideas that could change the trajectory of a brain tumor diagnosis. In 2020, the ABTA has awarded nearly $400,000 towards 11 new research grants to foster innovation in the diagnosis and treatment of brain tumors in adults and children.
Learn more about the ABTA Research program and available grant opportunities.